Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,640,493
+$826,806 QoQ
Shares Held
18,441
+5.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#1,359
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Morse Asset Management, Inc holds $27,585,966 across 9 Drug Manufacturers - General names. ABBV ranks #3 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,610 | $11,526,523 | |
| 2 | JNJ |
Johnson & Johnson
|
26,231 | $6,661,887 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
18,441 | $4,640,493 | |
| 4 | MRK |
Merck & Co., Inc.
|
32,843 | $4,220,325 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,000 | $288,100 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,354 | $171,064 | |
| 7 | AMGN |
Amgen Inc
|
200 | $72,424 | |
| 8 | GSK |
GSK plc
|
90 | $4,717 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,640,493 | 18,441 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,813,687 | 17,535 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,501,609 | 15,325 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,072,072 | 13,268 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,298,968 | 6,998 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,497,648 | 7,148 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,299,520 | 7,313 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,493,541 | 7,563 | Shares | Sole | 2024-11-20 | |
| 2024-06-30 | $1,267,189 | 7,388 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,436,404 | 7,888 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,222,713 | 7,890 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,326,634 | 8,900 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,059,179 | 22,706 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,093,492 | 57,059 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $9,428,165 | 58,339 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $7,888,326 | 58,776 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,038,890 | 59,016 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $9,212,062 | 56,826 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $8,049,665 | 59,451 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,345,560 | 58,826 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $6,904,719 | 61,299 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,771,217 | 62,569 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,159,410 | 57,484 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,452,988 | 50,839 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $5,032,608 | 51,259 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,261,312 | 42,805 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||